2,552
Views
20
CrossRef citations to date
0
Altmetric
Research Paper

Design, synthesis, and evaluation of curcumin analogues as potential inhibitors of bacterial sialidase

, , , , , , & show all
Pages 1256-1265 | Received 18 Sep 2017, Accepted 12 Jun 2018, Published online: 21 Aug 2018

References

  • Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016;315:801–10.
  • Martin GS. Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes. Expert Rev anti Infect Ther 2012;10:701–6.
  • Ispahani P, Slack RCB, Donald FE, et al. Twenty year surveillance of invasive pneumococcal disease in Nottingham: serogroups responsible and implications for immunization. Arch Dis Child 2004;89:757–62.
  • O'Brien KL, Wolfson LJ, Watt JP, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009;374:893–902.
  • Bogaert D, De Groot R, Hermans PW. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis 2004;4:144–54.
  • Mitchell TJ. Virulence factors and the pathogenesis of disease caused by Streptococcus pneumoniae. Res Microbiol 2000;151:413–9.
  • Yang L, Connaris H, Potter JA, et al. Structural characterization of the carbohydrate-binding module of Nan A sialidase: a pneumococcal virulence factor. BMC Struct Biol 2015;15:15.
  • Paton JC, Andrew PW, Boulnois GJ, et al. Molecular analysis of the pathogenicity of Streptococcus pneumoniae: the role of pneumococcal proteins. Annu Rev Microbiol 1993;47:89–115.
  • Lee Y, Ryu YB, Youn HS, et al. Structural basis of sialidase in complex with geranylated flavonoids as potent natural inhibitors. Acta Cryst 2014;70:1357–65.
  • Park JY, Lim SH, Kim BR, et al. Sialidase inhibitory activity of diarylnonanoid and neolignan compounds extracted from the seeds of Myristica fragrans. Bioorg Med Chem Lett 2017;27:3060–4.
  • Gut H, King SJ, Walsh MA. Structural and functional studies of Streptococcus pneumoniae neuraminidase B: an intramolecular trans-sialidase. FEBS Lett 2008;582:3348–52.
  • Coats MT, Murphy T, Paton JC, et al. Exposure of Thomsen-Friedenreich antigen in Streptococcus pneumoniae infection is dependent on pneumococcal neuraminidase A. Microb Pathog 2011;50:343–9.
  • Walther E, Xu Z, Richter M, et al. Dual acting neuraminidase inhibitors open new opportunities to disrupt the lethal synergism between Streptococcus pneumoniae and influenza virus. Front Microbiol 2016;7:357.
  • Huh J, Ha TKQ, Kang KB, et al. Methylated flavonoid glycosides from pentarhizidium orientale rhizomes and their inhibitory effects on the H1N1 influenza virus. J Nat Prod 2017; 80:2818–24.
  • Bang S, Li W, Ha TKQ, et al. Anti-influenza effect of the major flavonoids from Salvia plebeia R.Br. via inhibition of influenza H1N1 virus neuraminidase. Nat Prod Res 2017; 15:1–5.
  • Woo HS, Kim DW, Curtis-Long MJ, et al. Potent inhibition of bacterial neuraminidase activity by pterocarpans isolated from the roots of Lespedeza bicolor. Bioorg Med Chem Lett 2011; 21:6100–3.
  • Ryu YB, Jeong HJ, Yoon SY, et al. Influenza virus neuraminidase inhibitory activity of phlorotannins from the edible brown alga Ecklonia cava. J Agric Food Chem 2011; 59:6467–73.
  • Hoffmann A, Richter M, von Grafenstein S, et al. Discovery and characterization of diazenylaryl sulfonic acids as inhibitors of viral and bacterial neuraminidases. Front Microbiol 2017;8:205.
  • Grienke U, Richter M, Walther E, et al. Discovery of prenylated flavonoids with dual activity against influenza virus and Streptococcus pneumoniae. Sci Rep 2016;6:27156.
  • Uddin Z, Song YH, Curtis-Long MJ, et al. Potent bacterial neuraminidase inhibitors, anthraquinone glucosides from Polygonum cuspidatum and their inhibitory mechanism. J Ethnopharmacol 2016;193:283–92.
  • Nabavi SF, Daglia M, Moghaddam AH, et al. Curcumin and liver disease: from chemistry to medicine. Compr Rev Food Sci Food Saf 2014;13:62–77.
  • Dulbecco P, Savarino V. Therapeutic potential of curcumin in digestive diseases. World J Gastroenterol 2013;19:9256–70.
  • Majhi A, Rahman GM, Panchal S, et al. Binding of curcumin and its long chain derivatives to the activator binding domain of novel protein kinase C. Bioorg Med Chem 2010;18:1591–8.
  • Farnsworth NR, Bunyapraphatsara N. Thai medicinal plants: recommended for Primary health care system, Bangkok, Medicinal Plant Information Center 1992;409. (ISBN: 9745874981)
  • Chattopadhyay I, Biswas K, Bandyopadhyay U, et al. Turmeric and curcumin: Biological activity and medicinal applications. Curr Sci 2004;87:44–53.
  • Internet News. Turmeric – an effective therapy for Crohn's disease. Nat Prod Rad (CSIR) 2004;3:115
  • Mishra S, Palanivelu K. The effect of curcumin (turmeric) on Alzheimer’s disease: an overview. Ann Indian Acad Neurol 2008;11:13–9.
  • Endo H, Nikaido Y, Nakadate M, et al. Structure activity relationship study of curcumin analogues toward the amyloid-beta aggregation inhibitor. Bioorg Med Chem Lett 2014;24:5621–6.
  • Lin L, Shi Q, Nyarko AK, et al. Antitumor agents. 250. Design and synthesis of new curcumin analogues as potential anti-prostate cancer agents. J Med Chem 2006;49:3963–72.
  • Du ZY, Liu RR, Shao WY, et al. Alpha-glucosidase inhibition of natural curcuminoids and curcumin analogs. Eur J Med Chem 2006;41:213–8.
  • Pavolini T, Gambarin F, Grinzato AM. Curcumin and curcuminoids. Ann Chim Rome 1950;40:280–91.
  • Mohamad H, Lajis NH, Abas F, et al. Antioxidative constituents of Etlingera elatior. J Nat Prod 2005;68:285–8.
  • Caruso F, Pettinari R, Rossi M, et al. The in vitro antitumor activity of arene-ruthenium(II) curcuminoid complexes improves when decreasing curcumin polarity. J Inorg Biochem 2016;162:44–51.
  • Sagnou M, Mitsopoulou KP, Koliopoulos G, et al. Evaluation of naturally occurring curcuminoids and related compounds against mosquito larvae. Acta Trop 2012;123:190–5.
  • Feng JY, Liu ZQ. Phenolic and enolic hydroxyl groups in curcumin: which plays the major role in scavenging radicals? J Agric Food Chem 2009;57:11041–6.
  • Nichols CE, Youssef D, Harris RG, et al. Microwave-assisted synthesis of curcumin analogs. ARKIVOC 2016;13:64–72.
  • Lee SL, Huang WJ, Lin WW, et al. Preparation and anti-inflammatory activities of diarylheptanoid and diarylheptylamine analogs. Bioorg Med Chem 2005;13:6175–81.
  • Lozada MC, Enríquez RG, Lobato CE, et al. Synthesis and structure of new heterocyclic derivatives of curcumin. Heterocycles 2005;65:49–58.
  • Pabon HJJ. A synthesis of curcumin and related compounds. Recl Trav Chim Pays-Bas 2010;83:379–86.
  • Youssef D, Nichols CE, Cameron TS, et al. Design, synthesis, and cytostatic activity of novel cyclic curcumin analogues. Bioorg Med Chem Lett 2007;17:5624–9.
  • Fadda AA, Badria FA, El-Attar KM. Synthesis and evaluation of curcumin analogues as cytotoxic agents‏. Med Chem Res 2010;19:413–30.
  • Changtam C, Koning HP, Ibrahim H, et al. Curcuminoid analogs with potent activity against Trypanosoma and Leishmania species. Eur J Med Chem 2010;45:941–56.